Expertise in
12
conditions

Dr. Youn-hee Kim

Dermatology
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
12
conditions
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Youn-hee Kim is a Dermatologist in Palo Alto, California. Dr. Kim is highly rated in 12 conditions, according to our data. Her top areas of expertise are Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Sezary Syndrome.

Her clinical research consists of co-authoring 151 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in CA
Hospital Affiliations
Stanford Health Care
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Santa Clara Family Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 13 Less Insurance Carriers -

Locations

Stanford University
875 Blake Wilbur Dr, Palo Alto, CA 94304
Call: 650-498-6000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
Enrollment Status: Recruiting
Publish Date: October 22, 2025
A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
Enrollment Status: Terminated
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: TTI-621, Rituximab
Study Phase: Phase 1
A Phase II Trial of MK-3475 (Pembrolizumab) and Interferon Gamma 1-b Combination Immunotherapy in Patients With Previously Treated Mycosis Fungoides and Sezary Syndrome (Treatment Group 1) and in Patients With Advanced Synovial Sarcoma (Treatment Group 2)
A Phase II Trial of MK-3475 (Pembrolizumab) and Interferon Gamma 1-b Combination Immunotherapy in Patients With Previously Treated Mycosis Fungoides and Sezary Syndrome (Treatment Group 1) and in Patients With Advanced Synovial Sarcoma (Treatment Group 2)
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Other, Biological
Study Drugs: Interferon Gamma-1b, Pembrolizumab
Study Phase: Phase 2
A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma
A Phase II Study of Non-myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma
Enrollment Status: Completed
Publish Date: May 11, 2023
Intervention Type: Drug, Radiation
Study Drugs: Anti-Thymocyte Globulin, Cyclosporine
Study Phase: Phase 2
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell Lymphoma
Enrollment Status: Terminated
Publish Date: October 28, 2022
Intervention Type: Drug
Study Drug: Naloxone Hydrochloride Lotion
Study Phase: Phase 3
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

151 Total Publications

A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification.
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk Stratification.
Journal: Blood
Published: April 16, 2025
View All 151 Publications
Similar Doctors
Expertise in
136
conditions
Dr. Joyce Teng
Dermatology
Expertise in
136
conditions
Dr. Joyce Teng
Dermatology

Lpch Medical Group Div Of Lucile

725 Welch Rd, 
Palo Alto, CA 
 (0.2 miles away)
650-498-7200
Languages Spoken:
English
See accepted insurances

Joyce Teng is a Dermatologist in Palo Alto, California. Dr. Teng is highly rated in 136 conditions, according to our data. Her top areas of expertise are Lamellar Ichthyosis, Nonbullous Congenital Ichthyosiform Erythroderma, Nevoid Basal Cell Carcinoma Syndrome, Aplasia Cutis Congenita, and Liver Embolization.

David F. Fiorentino
Expertise in
16
conditions
Dr. David F. Fiorentino
Dermatology
Expertise in
16
conditions
Dr. David F. Fiorentino
Dermatology

Stanford Health Care

420 Broadway St, 
Redwood City, CA 
 (3.9 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances

Dr. David Fiorentino, MD is a Dermatologist in Redwood City, CA and has over 24 years of experience in the medical field. He graduated from Stanford University in 1998. He is affiliated with Stanford Health Care. Dr. Fiorentino is highly rated in 16 conditions, according to our data. His top areas of expertise are Dermatomyositis, Systemic Sclerosis (SSc), Scleroderma, and Calcinosis.

Expertise in
43
conditions
Dr. Dawn H. Siegel
Dermatology
Expertise in
43
conditions
Dr. Dawn H. Siegel
Dermatology
725 Welch Rd, 
Palo Alto, CA 
 (0.2 miles away)
650-497-8000
Languages Spoken:
English
See accepted insurances

Dawn Siegel is a Dermatologist in Palo Alto, California. Dr. Siegel is highly rated in 43 conditions, according to our data. Her top areas of expertise are PHACE Syndrome, Hemangioma, Aplasia Cutis Congenita, and Vascular Birthmark.

VIEW MORE Dermatologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kim's expertise for a condition
ConditionClose
  • Elite
  • Cutaneous T-Cell Lymphoma (CTCL)
    Dr. Kim is
    Elite
    . Learn about Cutaneous T-Cell Lymphoma (CTCL).
    See more Cutaneous T-Cell Lymphoma (CTCL) experts
  • Lymphomatoid Papulosis
    Dr. Kim is
    Elite
    . Learn about Lymphomatoid Papulosis.
    See more Lymphomatoid Papulosis experts
  • Mycosis Fungoides
    Dr. Kim is
    Elite
    . Learn about Mycosis Fungoides.
    See more Mycosis Fungoides experts
  • Sezary Syndrome
    Dr. Kim is
    Elite
    . Learn about Sezary Syndrome.
    See more Sezary Syndrome experts
  • T-Cell Lymphoma
    Dr. Kim is
    Elite
    . Learn about T-Cell Lymphoma.
    See more T-Cell Lymphoma experts
  • Distinguished
  • Anaplastic Large Cell Lymphoma
    Dr. Kim is
    Distinguished
    . Learn about Anaplastic Large Cell Lymphoma.
    See more Anaplastic Large Cell Lymphoma experts
  • Advanced
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
    Dr. Kim is
    Advanced
    . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
    See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
  • Lymphocytic Infiltrate of Jessner
    Dr. Kim is
    Advanced
    . Learn about Lymphocytic Infiltrate of Jessner.
    See more Lymphocytic Infiltrate of Jessner experts
  • Marginal Zone Lymphoma (MZL)
    Dr. Kim is
    Advanced
    . Learn about Marginal Zone Lymphoma (MZL).
    See more Marginal Zone Lymphoma (MZL) experts
  • Peripheral T-Cell Lymphoma
    Dr. Kim is
    Advanced
    . Learn about Peripheral T-Cell Lymphoma.
    See more Peripheral T-Cell Lymphoma experts
  • Pustules
    Dr. Kim is
    Advanced
    . Learn about Pustules.
    See more Pustules experts
  • Squamous Cell Skin Carcinoma
    Dr. Kim is
    Advanced
    . Learn about Squamous Cell Skin Carcinoma.
    See more Squamous Cell Skin Carcinoma experts
  • Experienced
  • Acne
    Dr. Kim is
    Experienced
    . Learn about Acne.
    See more Acne experts
  • Actinic Keratosis
    Dr. Kim is
    Experienced
    . Learn about Actinic Keratosis.
    See more Actinic Keratosis experts
  • ADULT Syndrome
    Dr. Kim is
    Experienced
    . Learn about ADULT Syndrome.
    See more ADULT Syndrome experts
  • Atopic Dermatitis
    Dr. Kim is
    Experienced
    . Learn about Atopic Dermatitis.
    See more Atopic Dermatitis experts
  • Contact Dermatitis
    Dr. Kim is
    Experienced
    . Learn about Contact Dermatitis.
    See more Contact Dermatitis experts
  • Cutaneous Lupus Erythematosus (CLE)
    Dr. Kim is
    Experienced
    . Learn about Cutaneous Lupus Erythematosus (CLE).
    See more Cutaneous Lupus Erythematosus (CLE) experts
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Dermatologists Palo Alto, CA
  3. Dr. Youn-hee Kim
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.